Cargando…
A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency
Reports describing symptoms and treatment of patients with congenital factor VII (FVII) deficiency frequently relate to patients in Europe, while only a small number describe data from Asian countries. This multicenter, prospective observational study (NCT01312636) collected data from 30 sites for 5...
Autores principales: | Seita, Ikuo, Kinai, Ei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328502/ https://www.ncbi.nlm.nih.gov/pubmed/37395185 http://dx.doi.org/10.1097/MBC.0000000000001225 |
Ejemplares similares
-
Conformational Changes of Congenital FVII Variants with Defective Binding to Tissue Factor ARG304GLN (FVII Padua), ARG 304TRP (FVII Nagoya) and ARG79GLN (FVII Shinjo or Tondabayashi)
por: Cristiani, Andrea, et al.
Publicado: (2013) -
Expression of recombinant human coagulation factors VII (rFVII) and IX (rFIX) in various cell types, glycosylation analysis, and pharmacokinetic comparison
por: Böhm, Ernst, et al.
Publicado: (2011) -
The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMI
por: Demetz, Gabriele, et al.
Publicado: (2014) -
Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic
por: Jain, Shilpa, et al.
Publicado: (2018) -
Molecular Genetic Analysis of Russian Patients with Coagulation Factor FVII Deficiency
por: Pshenichnikova, Olesya, et al.
Publicado: (2023)